Adaptimmune Announces Closing Of $42 Million Registered Direct Offering - BioLegacy Research

Adaptimmune Announces Closing Of $42 Million Registered Direct Offering

Post author:Sam
Post published:April 10, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace